Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Myhibbin
.
Show all posts
Showing posts with label
Myhibbin
.
Show all posts
Tuesday, September 24, 2024
FDA Approves Myhibbin (mycophenolate mofetil) Oral Suspension for Prophylaxis of Organ Rejection
›
Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the need...
›
Home
View web version